Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden settingMore about Open Access at the Crick
Authors listEmily A Kendall Andrew S Azman Gary Maartens Andrew Boulle Robert Wilkinson David W Dowdy Molebogeng X Rangaka
Both isoniazid preventive therapy (IPT) and antiretroviral therapy (ART) reduce tuberculosis risk in individuals living with HIV. We sought to estimate the broader, population-wide impact of providing a pragmatically implemented 12-month IPT regimen to ART recipients in a high-burden community.
Issue number 3